Ma. Fatima Francisco Procter & Gamble CO (PG) insider trading activity

Ma. Fatima Francisco is CEO - Baby, Fem & Family Care of PROCTER & GAMBLE Co. Currently has a direct ownership of 13,727 shares of PG, which is worth approximately $2.32 Million. The most recent transaction as insider was on Dec 07, 2022, when has been sold 58 shares (Common Stock) at a price of $149.18 per share, resulting in proceeds of $8,652. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.7K

0.04% 3M change

23.37% 12M change

Total Value Held $2.32 Million

Ma. Fatima Francisco Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 07 2022	BUY Exercise of conversion of derivative security	$8,652 $149.18 p/Share	58 Added 0.33%	17,395 Common Stock
Aug 17 2022	SELL Open market or private sale	$1,829,591 $149.33 p/Share	12,252 Reduced 41.42%	17,331 Common Stock
Aug 16 2022	SELL Open market or private sale	$8,751,431 $149.5 p/Share	58,538 Reduced 98.28%	1,025 Common Stock
Aug 16 2022	BUY Grant, award, or other acquisition	-	28,552 Added 49.11%	29,583 Common Stock
Aug 16 2022	BUY Exercise of conversion of derivative security	$4,700,016 $80.29 p/Share	58,538 Added 49.57%	59,563 Common Stock
Aug 15 2022	SELL Open market or private sale	$2,660,300 $148.0 p/Share	17,975 Reduced 94.61%	1,025 Common Stock
Aug 15 2022	BUY Exercise of conversion of derivative security	$1,530,212 $85.13 p/Share	17,975 Added 48.61%	19,000 Common Stock
Aug 08 2022	SELL Open market or private sale	$584,000 $146.0 p/Share	4,000 Reduced 79.6%	1,025 Common Stock
Aug 03 2022	SELL Open market or private sale	$290,000 $145.0 p/Share	2,000 Reduced 28.47%	5,025 Common Stock
Apr 21 2022	SELL Open market or private sale	$2,957,940 $164.33 p/Share	18,000 Reduced 71.94%	7,020 Common Stock
Apr 21 2022	BUY Exercise of conversion of derivative security	$1,362,080 $85.13 p/Share	16,000 Added 41.0%	23,020 Common Stock
Dec 06 2021	SELL Payment of exercise price or tax liability	$7,144 $148.83 p/Share	48 Reduced 0.53%	9,015 Common Stock
Dec 06 2021	BUY Exercise of conversion of derivative security	$7,144 $148.83 p/Share	48 Added 0.53%	9,063 Common Stock
Nov 22 2021	SELL Open market or private sale	$1,204,266 $148.4 p/Share	8,115 Reduced 47.37%	9,015 Common Stock
Nov 22 2021	BUY Exercise of conversion of derivative security	$680,605 $83.87 p/Share	8,115 Added 32.14%	17,130 Common Stock
Nov 05 2021	SELL Open market or private sale	$496,400 $146.0 p/Share	3,400 Reduced 27.4%	9,008 Common Stock
Nov 03 2021	SELL Open market or private sale	$493,000 $145.0 p/Share	3,400 Reduced 21.51%	12,408 Common Stock
Oct 26 2021	SELL Open market or private sale	$171,600 $143.0 p/Share	1,200 Reduced 7.06%	15,808 Common Stock
Aug 19 2021	SELL Open market or private sale	$536,935 $145.0 p/Share	3,703 Reduced 17.88%	17,008 Common Stock
Aug 17 2021	SELL Open market or private sale	$1,404,143 $144.37 p/Share	9,726 Reduced 31.95%	20,711 Common Stock
Aug 17 2021	BUY Grant, award, or other acquisition	-	25,841 Added 45.92%	30,437 Common Stock
Aug 03 2021	SELL Open market or private sale	$500,500 $143.0 p/Share	3,500 Reduced 43.26%	4,591 Common Stock
May 17 2021	SELL Open market or private sale	$417,000 $139.0 p/Share	3,000 Reduced 27.05%	8,091 Common Stock
May 06 2021	SELL Open market or private sale	$405,000 $135.0 p/Share	3,000 Reduced 21.3%	11,085 Common Stock
Apr 21 2021	SELL Open market or private sale	$514,275 $137.14 p/Share	3,750 Reduced 21.03%	14,085 Common Stock

Also insider at

HPQ

HP INC Technology

OGN

Organon & Co. Healthcare

Director

MFF